The trademark application ALMISAS was filed by G.L. Pharma GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on July 10, 2022, and it was registered by office on October 17, 2022 without any oppositions.
The application was filed in German (English was selected as the second language).